Nonalcoholic Fatty Liver Disease

被引：157

作者：

Wang, Xiao Jing ^{[1
]}

Malhi, Harmeet ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2018年 / 169卷 / 09期

关键词：

HEPATIC STEATOSIS; UNITED-STATES; WEIGHT-LOSS; VITAMIN-E; STEATOHEPATITIS; CIRRHOSIS; FIBROSIS; DIAGNOSIS; TRANSPLANTATION; UTILITY;

D O I：

10.7326/AITC201811060

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：ITC65 / ITC80

页数：16

共 49 条

[11] Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan® [J].

de Ledinghen, Victor ;

Wong, Vincent Wai-Sun ;

Vergniol, Julien ;

Wong, Grace Lai-Hung ;

Foucher, Juliette ;

Chu, Shirley Ho-Ting ;

Le Bail, Brigitte ;

Choi, Paul Cheung-Lung ;

Chermak, Faiza ;

Yiu, Karen Kar-Lum ;

Merrouche, Wassil ;

Chan, Henry Lik-Yuen .

JOURNAL OF HEPATOLOGY, 2012, 56 (04) :833-839

[12] Utility of a new model to diagnose an alcohol basis for steatohepatitis [J].

Dunn, Winston ;

Angulo, Paul ;

Sanderson, Schuyler ;

Jamil, Laith H. ;

Stadheim, Linda ;

Rosen, Charles ;

Malinchoc, Michael ;

Kamath, Patrick S. ;

Shah, Vijay H. .

GASTROENTEROLOGY, 2006, 131 (04) :1057-1063

[13] Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss [J].

Hallsworth, Kate ;

Fattakhova, Gulnar ;

Hollingsworth, Kieren G. ;

Thoma, Christian ;

Moore, Sarah ;

Taylor, Roy ;

Day, Christopher P. ;

Trenell, Michael I. .

GUT, 2011, 60 (09) :1278-1283

[14] NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial [J].

Harrison, Stephen A. ;

Rinella, Mary E. ;

Abdelmalek, Manal F. ;

Trotter, James F. ;

Paredes, Angelo H. ;

Arnold, Hays L. ;

Kugelmas, Marcelo ;

Bashir, Mustafa R. ;

Jaros, Mark J. ;

Ling, Lei ;

Rossi, Stephen J. ;

DePaoli, Alex M. ;

Loomba, Rohit .

LANCET, 2018, 391 (10126) :1174-1185

[15] Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End-Stage Liver Disease [J].

Heimbach, J. K. ;

Watt, K. D. S. ;

Poterucha, J. J. ;

Ziller, N. Francisco ;

Cecco, S. D. ;

Charlton, M. R. ;

Hay, J. E. ;

Wiesner, R. H. ;

Sanchez, W. ;

Rosen, C. B. ;

Swain, J. M. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (02) :363-368

[16] Hepatic Steatosis: Quantification by Proton Density Fat Fraction with MR Imaging versus Liver Biopsy [J].

Idilman, Ilkay S. ;

Aniktar, Hatice ;

Idilman, Ramazan ;

Kabacam, Gokhan ;

Savas, Berna ;

Elhan, Atilla ;

Celik, Azim ;

Bahar, Kadir ;

Karcaaltincaba, Musturay .

RADIOLOGY, 2013, 267 (03) :767-775

[17] Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis [J].

Lefebvre, Eric ;

Moyle, Graeme ;

Reshef, Ran ;

Richman, Lee P. ;

Thompson, Melanie ;

Hong, Feng ;

Chou, Hsin-I ;

Hashiguchi, Taishi ;

Plato, Craig ;

Poulin, Dominic ;

Richards, Toni ;

Yoneyama, Hiroyuki ;

Jenkins, Helen ;

Wolfgang, Grushenka ;

Friedman, Scott L. .

PLOS ONE, 2016, 11 (06)

[18] Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus [J].

Leite, Nathalie C. ;

Salles, Gil F. ;

Araujo, Antonio L. E. ;

Villela-Nogueira, Cristiane A. ;

Cardoso, Claudia R. L. .

LIVER INTERNATIONAL, 2009, 29 (01) :113-119

[19] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial [J].

Lindor, KD ;

Kowdley, KV ;

Heathcote, EJ ;

Harrison, ME ;

Jorgensen, R ;

Angulo, P ;

Lymp, JF ;

Burgart, L ;

Colin, P .

HEPATOLOGY, 2004, 39 (03) :770-778

[20]

Loomba R, 2018, HEPATOLOGY

← 1 2 3 4 5 →